ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$730M |
| 2 |
Robinhood
HOOD
|
+$449M |
| 3 |
SGFY
Signify Health, Inc.
SGFY
|
+$358M |
| 4 |
Coinbase
COIN
|
+$339M |
| 5 |
Ginkgo Bioworks
DNA
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.05B |
| 2 |
Sea Limited
SE
|
+$576M |
| 3 |
XYZ
Block Inc
XYZ
|
+$493M |
| 4 |
Shopify
SHOP
|
+$445M |
| 5 |
P
Everpure Inc
P
|
+$337M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.46% |
| 2 | Technology | 28.71% |
| 3 | Communication Services | 13.55% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Financials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Twist Bioscience
TWST
$7.25B
| $422M | 1.01% |
3,946,409
-1,108,455
| -22% | -$127M |
|
|
27
Robinhood
HOOD
$83.9B
| $416M | 1% |
+9,876,801
| New | +$449M |
|
28
PagerDuty
PD
$902M
| $414M | 0.99% |
9,996,968
+1,403,361
| +16% | +$59.5M |
|
|
TSP
29
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $383M | 0.92% |
10,314,228
+3,841,493
| +59% | +$162M |
|
30
Trimble
TRMB
$13.9B
| $365M | 0.88% |
4,433,239
-825,154
| -16% | -$72.5M |
|
31
Veracyte
VCYT
$3.8B
| $324M | 0.78% |
6,980,201
+290,938
| +4% | +$12.7M |
|
|
SGFY
32
DELISTED
Signify Health, Inc.
SGFY
| $320M | 0.77% |
17,933,990
+13,917,369
| +346% | +$358M |
|
33
Vertex Pharmaceuticals
VRTX
$126B
| $310M | 0.74% |
1,709,751
-64,315
| -4% | -$12.6M |
|
|
34
Sea Limited
SE
$69.5B
| $304M | 0.73% |
953,280
-1,876,637
| -66% | -$576M |
|
35
Iovance Biotherapeutics
IOVA
$2.87B
| $287M | 0.69% |
11,649,837
-6,800,876
| -37% | -$160M |
|
36
Ionis Pharmaceuticals
IONS
$9.4B
| $285M | 0.69% |
8,511,384
-396,349
| -4% | -$14.9M |
|
|
TWOU
37
DELISTED
2U Inc
TWOU
| $282M | 0.68% |
280,409
-32,328
| -10% | -$37.9M |
|
|
38
Ginkgo Bioworks
DNA
$521M
| $269M | 0.65% |
+580,771
| New | +$283M |
|
39
Regeneron Pharmaceuticals
REGN
$80.8B
| $259M | 0.62% |
428,147
-284,901
| -40% | -$177M |
|
40
Editas Medicine
EDIT
$442M
| $259M | 0.62% |
6,297,359
-882,696
| -12% | -$48.4M |
|
41
Takeda Pharmaceutical
TAK
$55.7B
| $221M | 0.53% |
13,501,650
-1,991,347
| -13% | -$33.4M |
|
|
ACCD
42
DELISTED
Accolade Inc
ACCD
| $221M | 0.53% |
5,231,496
-185,510
| -3% | -$8.72M |
|
43
CareDx
CDNA
$2.42B
| $216M | 0.52% |
3,410,153
-1,153,957
| -25% | -$87.9M |
|
44
Kratos Defense & Security Solutions
KTOS
$11.4B
| $213M | 0.51% |
9,563,962
+1,218,325
| +15% | +$30.1M |
|
45
Veeva Systems
VEEV
$37.4B
| $212M | 0.51% |
736,180
-139,409
| -16% | -$44.2M |
|
46
PayPal
PYPL
$50.5B
| $198M | 0.48% |
762,007
-203,626
| -21% | -$57.8M |
|
47
Incyte
INCY
$24.4B
| $198M | 0.47% |
2,872,346
-76,621
| -3% | -$5.82M |
|
|
FIRY
48
Firy Inc
FIRY
$163M
| $185M | 0.44% |
941,805
-288,389
| -23% | -$74.6M |
|
49
Protolabs
PRLB
$2.13B
| $174M | 0.42% |
2,619,323
-411,307
| -14% | -$32.1M |
|
50
JD.com
JD
$44.5B
| $173M | 0.42% |
2,399,639
-3,875,078
| -62% | -$286M |
|
Similar funds
ARK Investment Management's Q3 2021 Portfolio in Review
As of Q3 2021, ARK Investment Management held 337 positions worth $41.6B, down 23% from $53.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
ARK Investment Management withdrew a net $4.54B in Q3 2021, closing 38 positions and reducing 174 holdings. Its most notable exit was Everpure Inc, an estimated $337M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Communication Services.
Against the trend, ARK Investment Management opened a new position in Robinhood worth $416M.
- ARK Investment Management's largest Q3 2021 buy was Robinhood: 9,876,801 shares worth $416M.
- ARK Investment Management added most to UiPath in Q3 2021, an estimated $730M increase.
- ARK Investment Management's biggest Q3 2021 reduction was Tesla, cutting an estimated $1.05B.
- ARK Investment Management fully exited Everpure Inc in Q3 2021, selling an estimated $337M.
- ARK Investment Management's ten largest holdings make up 38% of its $41.6B portfolio in Q3 2021.
- ARK Investment Management opened 52 new positions and closed 38 in Q3 2021.
- ARK Investment Management's portfolio value fell 23% quarter-over-quarter to $41.6B.
Based on ARK Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.